Both in Pharmaceuticals
Arcutis Biotherapeutics vs Dianthus Therapeutics
Over the past year ARQT returned +61.8% and DNTH returned +138.5%; their daily moves had a correlation of 0.33.
ARQT +61.8% DNTH +138.5%Growth of $1, one year, split-adjusted
| Metric | ARQT | DNTH |
|---|---|---|
| Price | $31.78 | $79.96 |
| Market cap | $4.00B | $4.47B |
| Today | +0.33% | +0.55% |
| 1 month | +18.8% | −8.3% |
| 6 months | +42.1% | −4.2% |
| Year to date | +9.5% | +94.0% |
| 1 year | +61.8% | +138.5% |
| Revenue growth (YoY) | +59.3% | +294.3% |
| Gross margin | 91.6% | 100.0% |
| Net margin | 11.6% | −6598.6% |
| P/E (TTM) | 140.1× | — |
| Price / sales | 8.6× | 2,349.0× |
| Net cash | $129.7M | $886.8M |
| Dividend yield | — | — |
| Volatility (60d) | 54.8% | 38.4% |
| Short % of float | 18.0% | 18.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).